Skip to content

Effect of Inspiratory Muscle Training During PR on Dyspnoea and Exercise Tolerance in COPD Patients

Effect of Inspiratory Muscle Training During PR on Dyspnoea and Exercise Tolerance in Chronic Obstructive (COPD)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04120142
Enrollment
34
Registered
2019-10-09
Start date
2019-02-01
Completion date
2019-12-01
Last updated
2020-02-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Obstructive Pulmonary Disease

Keywords

COPD, IMT, 6MWT, Dyspoea, SGRQ

Brief summary

Chronic obstructive pulmonary disease is a respiratory disease that results in progressive airflow limitation and respiratory distress. The benefit of inspiratory muscle training (IMT) combined with a pulmonary rehabilitation programme is uncertain. The investigators aimed to demonstrate that, in patients with obstructive pulmonary disease, IMT performed during a PRP is associated with an improvement of dyspnoea and exercise tolerance.

Detailed description

The purpose of this study is to evaluate the effect of the inspiratory muscle training (with incremental load every two weeks in two months) performed during pulmonary rehabilitation on dyspnoea, 6 minutes walk test and quality of life using the St George's respiratory questionnaire (SGRQ) in COPD patients.

Interventions

OTHERPulmonary rehabilitation+IMT

The experimental group receives inspiratory muscle training and aerobic exercise.

OTHERPulmonary rehabilitation

The Active Comparator group received only aerobic exercise.

Sponsors

Faculty of Medicine, Sousse
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Caregiver)

Eligibility

Sex/Gender
MALE
Age
45 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Were COPD diagnosed by pulmonary function testing * Clinically stable * Abscence of other obstructive diseases * Signed written consert

Exclusion criteria

* Were previous pneumonectomy or lobectomy in the past 6 months * spontaneous risk of pneumothorax or rib fracture * Incapacity to follow a standard rehabilitation programme (locomotor deficits, acute cardiac failure and acute exacerbation of COPD at the beginning of the programme) * The absence of written informed consent.

Design outcomes

Primary

MeasureTime frameDescription
DyspnoeaBaseline, After 2 monthsThe dyspnoea were measured before and after the 6 minutes walk test
Inspiratory muscle strengthBaseline, After 2 monthsThe inspiratory muscle strength were measured by maximal inspiratory pressure test

Countries

Tunisia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026